Synthetic cannabinoids and cardiac arrhythmia risk: review of the literature

Basit Öğe Kaydı
dc.authoridErtan Yetkin / 0000-0001-8862-750X
dc.authorscopusidErtan Yetkin / 7004009443
dc.authorwosidErtan Yetkin / AGX-3712-2022
dc.contributor.authorÖztürk, Hayriye Mihrimah
dc.contributor.authorYetkin, Ertan
dc.contributor.authorÖztürk, Selçuk
dc.date.accessioned2020-08-30T20:06:48Z
dc.date.available2020-08-30T20:06:48Z
dc.date.issued2019
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractSynthetic cannabinoids (SCBs) are widely used recreational substances especially among adults. Although they have been considered as safe during the marketing process, our knowledge about their adverse effects has evolved since years. SCBs are associated with various cardiac events including acute myocardial infarction and sudden cardiac death. There is also growing evidence that SCBs are associated with cardiac arrhythmia development both in acute and chronic exposure. SCBs have been shown to be associated with both supraventricular and ventricular arrhythmias. However, the exact mechanism of the SCB related arrhythmia remains unknown. Understanding the exact association and possible mechanisms may help us to identify high risk patients at an early stage and to develop treatment modalities to prevent or reverse the arrhythmic effects of SCBs.en_US
dc.identifier.citationOzturk, H. M., Yetkin, E., & Ozturk, S. (2019). Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature. CARDIOVASCULAR TOXICOLOGY, 19(3), 191–197. https://doi.org/10.1007/s12012-019-09522-zen_US
dc.identifier.doi10.1007/s12012-019-09522-zen_US
dc.identifier.endpage197en_US
dc.identifier.issn1530-7905en_US
dc.identifier.issn1559-0259en_US
dc.identifier.issue3en_US
dc.identifier.pmid31030341en_US
dc.identifier.scopus2-s2.0-85064931222en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage191en_US
dc.identifier.urihttps://doi.org/10.1007/s12012-019-09522-z
dc.identifier.urihttps://hdl.handle.net/20.500.12713/625
dc.identifier.volume19en_US
dc.identifier.wosWOS:000467438300001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorYetkin, Ertanen_US
dc.language.isoenen_US
dc.publisherHumana Press Incen_US
dc.relation.ispartofCardiovascular Toxicologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSynthetic Cannabinoiden_US
dc.subjectArrhythmiaen_US
dc.subjectCardiovascular Systemen_US
dc.subjectSupraventricular Arrhythmiaen_US
dc.subjectVentricular Arrhythmiaen_US
dc.titleSynthetic cannabinoids and cardiac arrhythmia risk: review of the literatureen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
281.pdf
Boyut:
625.31 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu